Evidence map›Paper›PMID 33224573›Full record

ArticleAmerican journal of blood research2020

Jay Singh, Rajive Kumar, Deepak Verma, Nishi Rajput, Jayanth Kumar Palanichamy, Gunjan Sharma, Sameer Bakhshi, Atul Sharma, Deepam Pushpam, Rachna Seth and 6 more

Open access · greenAbstract read
In one paragraph

Article in American journal of blood research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Jay SinghLaboratory Oncology Unit, Dr. BRAIRCH, AIIMS New Delhi, India.
Rajive KumarMahavir Cancer Sansthan Patna, Bihar, India.
Deepak VermaLaboratory Oncology Unit, Dr. BRAIRCH, AIIMS New Delhi, India.
Nishi RajputLaboratory Oncology Unit, Dr. BRAIRCH, AIIMS New Delhi, India.
Jayanth Kumar PalanichamyDepartment of Biochemistry, AIIMS New Delhi, India.
Gunjan SharmaDepartment of Biochemistry, AIIMS New Delhi, India.
Sameer BakhshiDepartment of Medical Oncology, AIIMS New Delhi, India.
Atul SharmaDepartment of Medical Oncology, AIIMS New Delhi, India.
Deepam PushpamDepartment of Medical Oncology, AIIMS New Delhi, India.
Rachna SethDepartment of Paediatrics, AIIMS New Delhi, India.
Amar RanjanLaboratory Oncology Unit, Dr. BRAIRCH, AIIMS New Delhi, India.
Pranay TanwarLaboratory Oncology Unit, Dr. BRAIRCH, AIIMS New Delhi, India.
Archna SinghDepartment of Biochemistry, AIIMS New Delhi, India.
Mohit AroraDepartment of Biochemistry, AIIMS New Delhi, India.
Sarita KumariLaboratory Oncology Unit, Dr. BRAIRCH, AIIMS New Delhi, India.
Anita ChopraLaboratory Oncology Unit, Dr. BRAIRCH, AIIMS New Delhi, India.
All India Institute of Medical Sciences Bhopal · INAll India Institute of Medical Sciences Raipur · IN

Funding

DBT-Wellcome Trust India Alliance IA/CPHI/17/1/503333Wellcome Trust
6 · The paper itself

Abstract

Emerging evidence suggests existence of three prognostically relevant molecular entities among immature T-ALL-early thymic precursor ALL (ETP-ALL), T-ALL with the absence of biallelic deletion of TCRγ chains (ABD) and

Indexed as

ABDETP-ALLMEF2CT-ALL

Identifiers

PMID33224573
PMCPMC7675123
OpenAlexW3109075050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.